Carboplatin trains macrophages for cardiac defence | Synapse
March 3, 2026
Carboplatin trains macrophages for cardiac defence
Key Points
Macrophages trained with carboplatin enhance cardiac defence and immune responses, improving recovery post-injury.
In vitro experiments demonstrated that carboplatin-treated macrophages significantly produced cytokines critical for heart protection.
Observational analysis across cardiac injury models highlighted the potential of carboplatin to modulate immune responses through macrophage activation.
This research suggests new therapeutic strategies for cardiac protection by leveraging macrophage function in heart tissues.